© Copyright Our Wall
5G
in Healthcare Industry Overview
The report "5G in Healthcare Market by Component
(Hardware, Connectivity, Services) Application (Remote Patient Monitoring,
Connected Medical Devices, AR/VR, Connected Ambulance, Asset Tracking) End User
(Healthcare Providers, Payers) - Global Forecast to 2026", size is
projected to reach USD 3,667 million by 2026, at a CAGR of 76.3% between 2021
and 2026.
Gather more insights about the market drivers, restrains
and growth of the 5G
in Healthcare Market
The introduction of 5G technology in healthcare has enabled
the development of several advanced applications such as remote patient
monitoring, telemedicine, and artificial intelligence. These advanced
applications enable healthcare providers to provide better services to their
patients and improve the overall efficiency of healthcare services.
5G technology is expected to provide better data security
and enable healthcare providers to store large amounts of data securely. It can
also help healthcare providers in reducing the time taken to process medical
images and other medical data.
The increasing adoption of mobile devices and the growing
demand for advanced healthcare monitoring systems are the major factors driving
the 5G in healthcare market. The growing demand for advanced telemedicine
services and the increasing adoption of connected healthcare systems are also
expected to fuel the market growth.
The increasing investments in 5G technology by governments
of various countries are expected to create favorable opportunities for the 5G
in healthcare market. Companies operating in the market are also focusing on
developing advanced 5G enabled healthcare solutions to meet the growing demand.
Asia Pacific was the largest regional market for 5G in
healthcare market
The global 5G in healthcare market is segmented into five
major regions, namely, North America, Europe, the Asia Pacific, Latin America,
and the Middle East & Africa. Asia Pacific accounted for the largest share
of 33.8% of the global market. The APAC is the largest and fastest-growing
region in the 5G in healthcare market.
Key
Market Players
The prominent players in the 5G in healthcare market are
AT&T (US), Verizon (US), China Mobile Limited (China), Qualcomm (US),
T-Mobile (US), Ericsson (Sweden), Telit (Poland), Telus (Canada), Vodafone
(UK), Nokia (Finland), Samsung (South Korea), Deutsche Telekom AG (Germany),
Orange S.A. (France), SK Telecom Co., Ltd. (South Korea), BT Group (UK), NTT
DOCOMO (UK), NEC Corporation (Japan), Telefónica (Spain), Airtel (India),
Huawei Technologies Co., Ltd. (China), and Cisco (US).
The study categorizes the 5G in healthcare market into
following segments & sub-segments:
By Component
By Application
By End Users
By Region
Market Share Insights
Order
a free sample PDFof the 5G in Healthcare Market Intelligence Study,
published by MarketsandMarkets
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on
30,000 high growth niche opportunities/threats which will impact 70% to 80% of
worldwide companies’ revenues. Currently servicing 7500 customers worldwide
including 80% of global Fortune 1000 companies as clients. Almost 75,000 top
officers across eight industries worldwide approach MarketsandMarkets™ for
their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are
tracking global high growth markets following the "Growth Engagement Model
– GEM". The GEM aims at proactive collaboration with the clients to
identify new opportunities, identify most important customers, write
"Attack, avoid and defend" strategies, identify sources of
incremental revenues for both the company and its competitors.
MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top
players across leaders, emerging companies, innovators, strategic players)
annually in high growth emerging segments. MarketsandMarkets™ is determined to
benefit more than 10,000 companies this year for their revenue planning and
help them take their innovations/disruptions early to the market by providing
them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and
market research platform, "Knowledgestore" connects over 200,000
markets and entire value chains for deeper understanding of the unmet insights
along with market sizing and forecasts of niche markets.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
Sterilization Container Systems Market: Introduction
According to the new market research report "Sterilization
Container Systems Market by Product (Sterilization Containers,
Accessories), Type (Perforated, Non-Perforated), Material (Stainless Steel,
Aluminium, Other Materials), Technology (Filter, Valve) - Global Forecast to
2026", published by MarketsandMarkets™, the market is projected to reach
USD 375 million by 2026 from USD 324 million in 2021, at a CAGR of 3.0% during
the forecast period.
Get Sample Copy of the Report @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=240024631
Rising incidence of Hospital Acquired Infections
Hospital-acquired infections (HAIs) are major complications
in healthcare management and cause morbidity and mortality. Surgical site
infections (SSIs) are commonly occurring HAIs, attributed to the surgical
placement of prosthesis or implants or caused by exposure to instruments and
materials brought during an operation, surgical tools, surgical personnel, the
operating environment, and endogenous flora. The most common bacteria
associated with HAIs include C. difficile, methicillin-resistant Staphylococcus
aureus (MRSA), Klebsiella, E. coli, Enterococcus, and Pseudomonas. The growing
prevalence of HAIs is the primary growth driver for the sterilization container
systems market.
Use of sterilization wraps or pouches
Sterilization wraps are commonly used to pack surgical
instruments to protect them from the air, airborne pathogens, and moisture.
These wraps are compatible with both high and low-temperature sterilization
methods and available in various dimensions. Healthcare professionals in
developing countries are increasingly adopting disposable wraps, which are less
expensive than sterilization containers.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=240024631
Aluminum segment accounted for the largest share of the
sterilization container systems market and is also expected to grow at the
highest CAGR during the forecast period.
Based on the material, the sterilization container systems
market is segmented into aluminum, stainless steel, and other materials. the
aluminum sterilization containers segment accounted the largest share of the
sterilization container systems market.
The perforated sterilization containers segment is
expected to grow at the highest CAGR during the forecast period and also
accounted for the largest share
Based on type, sterilization container systems can be
perforated and non-perforated. Perforated sterilization containers accounted
for the largest share of the sterilization container systems market.
North America was the largest regional market for the
sterilization containers systems market
The sterilization containers systems market is segmented
into four major regions, namely, North America, Europe, Asia Pacific, and the
Rest of the World (RoW). North America was the largest regional market for
sterilization containers systems market
Competition Landscape of Sterilization Container Systems
Market
The global sterilization container systems market is
fragmented. The prominent players operating in this market include B. Braun
Melsungen AG (Germany), Johnson & Johnson (US), Becton, Dickinson and
Company (BD) (US), Integra LifeSciences Corporation (US), Medline Industries,
Inc. (US), KLS Martin Group (US), Ritter GmbH (Germany), MELAG Medizintechnik
GmbH & Co. KG (Germany), Hu-Friedy Mfg. Co., LLC (US), Case Medical (US),
Summit Medical LLC. (US), GPC Medical Ltd. (India), AYGÜN Co., Inc. (Turkey),
C.B.M. S.r.l. Medical Equipment (Italy), GPC Medical Ltd. (India), and EMED
(Poland).
Enquiry before Buying @ https://www.marketsandmarkets.com/RequestNewVersion.asp?id=240024631
This report categorizes the sterilization container
systems market into the following segments and subsegments:
By Product
By Type
By Technology
By Material
By Region
Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=240024631
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on
30,000 high growth niche opportunities/threats which will impact 70% to 80% of
worldwide companies' revenues. Currently servicing 7500 customers worldwide
including 80% of global Fortune 1000 companies as clients. Almost 75,000 top
officers across eight industries worldwide approach MarketsandMarkets™ for
their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are
tracking global high growth markets following the "Growth Engagement Model
– GEM". The GEM aims at proactive collaboration with the clients to
identify new opportunities, identify most important customers, write
"Attack, avoid and defend" strategies, identify sources of
incremental revenues for both the company and its competitors.
MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top
players across leaders, emerging companies, innovators, strategic players)
annually in high growth emerging segments. MarketsandMarkets™ is determined to
benefit more than 10,000 companies this year for their revenue planning and
help them take their innovations/disruptions early to the market by providing
them research ahead of the curve.
MarketsandMarkets's flagship competitive intelligence and
market research platform, "Knowledge Store" connects over 200,000
markets and entire value chains for deeper understanding of the unmet insights
along with market sizing and forecasts of niche markets.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: [email protected]
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/sterilization-container-systems-market.asp
Visit Our Web Site: https://www.marketsandmarkets.com
Content Source: https://www.marketsandmarkets.com/PressReleases/sterilization-container-systems.asp
The global protein A resin market is projected to reach USD 2.1 billion by 2028 from USD 1.2 billion in 2022, growing at a CAGR of 9.8% during the forecast period. Rising technological advancements primarily drive the growth of this market in protein A resin, rise in demand for miniaturize protein engineered product used in disease diagnoses and therapeutics. equipment further supports the market growth. However, higher initial investment impedes the market growth.
Protein A Resin Market: Competitive Landscape and Key Developments
The protein A resin business is very competitive, with both established companies and newcomers competing for the same market share. As of 2022, the key players operating in the global protein A resin market are Danaher Corporation (US), Merck KGAa (Germany), Repligen Corporation (US), Tosoh Bioscience LLC (Japan), Thermo Fisher Scientific (US), Agilent Technologies Inc. (US), and PerkinElmer (US) among others.
Get PDF Brochure With Latest Insights @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=19196962
Danaher Corporation (US)
Danaher Corporation is a US-based company that designs, manufactures, and markets medical, industrial, and commercial products and services. The company operates through three business segments, namely, Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences business segment offers protein A resin products. This segment is further classified into Filtration, Mass Spectrometry, Cellular Analysis, Lab Automation & Centrifugation, Microscopy, and Genomics Consumables. In FY 2021, the US accounted for 38.3% of the company’s revenue, followed by China (13.5%), Germany (5%), and all other countries (43.2%). The company's presence across diverse geographies shields it from risks associated with adverse economic trends in a single region. It also provides it with exposure to a large addressable market, thus enhancing its topline.
Merck KGAA (Germany)
Merck KGaA is another major player in the protein A resin market. The company is a leading provider of chromatography consumables across the globe. It primarily focuses on expansions and new product launches as its key growth strategies to expand its presence in the global market. Merck has a significant focus on innovation. Over the last few years, the company has increased its R&D activities with a focus on providing its customers with advanced products. Through strong R&D, the company is extending its patent portfolio, which can help Merck gain an advantage over its competitors. Merck is consistently introducing new chromatography products in the market. The company is also focused on enhancing its geographic presence through expansions.
Objectives of the Study
· To define, describe, and forecast the protein A resin market on the basis of product, type, application, end user, and region
· To provide detailed information regarding the major factors influencing the growth potential of the global market (drivers, restraints, opportunities, challenges, and trends)
· To analyze the micro markets with respect to individual growth trends, future prospects, and contributions to the global market
· To analyze key growth opportunities in the global market for key stakeholders and provide details of the competitive landscape for market leaders
· To forecast the size of market segments and/or subsegments with respect to five major regions, namely, North America (US and Canada), Europe (Germany, France, the UK, Italy, Spain, and the RoE), Asia Pacific (Japan, China, India, Australia, South Korea, and the RoAPAC), and rest of the world.
· To profile the key players in the global market and comprehensively analyze their market shares and core competencies
· To track and analyze the competitive developments undertaken in the global protein A resin market, such as product launches, agreements, expansions, and & acquisitions
Buy This Complete Business Report @ https://www.marketsandmarkets.com/Purchase/purchase_reportNew.asp?id=19196962
Global Protein A Resin Market – Regional Scope
The global Protein A resin market is segmented into five major regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Among these, the North America region is expected to hold the largest share in the global Protein A resin market. This can be attributed to the presence of well-established biopharmaceutical companies in the region and the availability of advanced infrastructure for biopharmaceutical manufacturing. Moreover, the rapid growth of the biopharmaceutical industry in the region is also expected to propel the growth of the Protein A resin market in North America.
Europe is the second-largest region in the global Protein A resin market, due to the presence of a large number of biopharmaceutical companies and contract research organizations in the region. The Asia Pacific is expected to be the fastest-growing region in the global Protein A resin market, owing to the increasing demand for biopharmaceuticals in the region. The growing research and development activities in the region are also expected to contribute to the growth of the Protein A resin market in the region.
Recent Developments
· In September 2022, As part of its charitable efforts through the Agilent Foundation, Agilent Technologies partnered with Delaware State University (DSU) to boost the number of minority students who choose STEM careers.
· In October 2021, Tosoh Biosciences LLC completed the acquisition of Semba Biosciences, a privately held leading innovator in the field of multi-column chromatography (MCC) instrumentation and technology for the downstream purification of biologics.
· In September 2021, Repligen and Navigo completed their co-development of a novel affinity ligand that addresses aggregation issues associated with pH-sensitive antibodies and Fc-fusion proteins. This ligand, NGL-Impact HipH, is produced and supplied to Purolite for use in a platform usage resin product.
· In May 2021, The Life Sciences business of GE Healthcare was acquired by Danaher Corporation and rebranded as Cytiva.
Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=19196962
About MarketsandMarkets™
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.
The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.
The global protein A resin market is projected to reach USD 2.1 billion by 2028 from USD 1.2 billion in 2022, growing at a CAGR of 9.8% during the forecast period. Rising technological advancements primarily drive the growth of this market in protein A resin, rise in demand for miniaturize protein engineered product used in disease diagnoses and therapeutics. equipment further supports the market growth. However, higher initial investment impedes the market growth.
Protein A Resin Market: Competitive Landscape and Key Developments
The protein A resin business is very competitive, with both established companies and newcomers competing for the same market share. As of 2022, the key players operating in the global protein A resin market are Danaher Corporation (US), Merck KGAa (Germany), Repligen Corporation (US), Tosoh Bioscience LLC (Japan), Thermo Fisher Scientific (US), Agilent Technologies Inc. (US), and PerkinElmer (US) among others.
Get PDF Brochure With Latest Insights @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=19196962
Danaher Corporation (US)
Danaher Corporation is a US-based company that designs, manufactures, and markets medical, industrial, and commercial products and services. The company operates through three business segments, namely, Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences business segment offers protein A resin products. This segment is further classified into Filtration, Mass Spectrometry, Cellular Analysis, Lab Automation & Centrifugation, Microscopy, and Genomics Consumables. In FY 2021, the US accounted for 38.3% of the company’s revenue, followed by China (13.5%), Germany (5%), and all other countries (43.2%). The company's presence across diverse geographies shields it from risks associated with adverse economic trends in a single region. It also provides it with exposure to a large addressable market, thus enhancing its topline.
Merck KGAA (Germany)
Merck KGaA is another major player in the protein A resin market. The company is a leading provider of chromatography consumables across the globe. It primarily focuses on expansions and new product launches as its key growth strategies to expand its presence in the global market. Merck has a significant focus on innovation. Over the last few years, the company has increased its R&D activities with a focus on providing its customers with advanced products. Through strong R&D, the company is extending its patent portfolio, which can help Merck gain an advantage over its competitors. Merck is consistently introducing new chromatography products in the market. The company is also focused on enhancing its geographic presence through expansions.
Objectives of the Study
· To define, describe, and forecast the protein A resin market on the basis of product, type, application, end user, and region
· To provide detailed information regarding the major factors influencing the growth potential of the global market (drivers, restraints, opportunities, challenges, and trends)
· To analyze the micro markets with respect to individual growth trends, future prospects, and contributions to the global market
· To analyze key growth opportunities in the global market for key stakeholders and provide details of the competitive landscape for market leaders
· To forecast the size of market segments and/or subsegments with respect to five major regions, namely, North America (US and Canada), Europe (Germany, France, the UK, Italy, Spain, and the RoE), Asia Pacific (Japan, China, India, Australia, South Korea, and the RoAPAC), and rest of the world.
· To profile the key players in the global market and comprehensively analyze their market shares and core competencies
· To track and analyze the competitive developments undertaken in the global protein A resin market, such as product launches, agreements, expansions, and & acquisitions
Buy This Complete Business Report @ https://www.marketsandmarkets.com/Purchase/purchase_reportNew.asp?id=19196962
Global Protein A Resin Market – Regional Scope
The global Protein A resin market is segmented into five major regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Among these, the North America region is expected to hold the largest share in the global Protein A resin market. This can be attributed to the presence of well-established biopharmaceutical companies in the region and the availability of advanced infrastructure for biopharmaceutical manufacturing. Moreover, the rapid growth of the biopharmaceutical industry in the region is also expected to propel the growth of the Protein A resin market in North America.
Europe is the second-largest region in the global Protein A resin market, due to the presence of a large number of biopharmaceutical companies and contract research organizations in the region. The Asia Pacific is expected to be the fastest-growing region in the global Protein A resin market, owing to the increasing demand for biopharmaceuticals in the region. The growing research and development activities in the region are also expected to contribute to the growth of the Protein A resin market in the region.
Recent Developments
· In September 2022, As part of its charitable efforts through the Agilent Foundation, Agilent Technologies partnered with Delaware State University (DSU) to boost the number of minority students who choose STEM careers.
· In October 2021, Tosoh Biosciences LLC completed the acquisition of Semba Biosciences, a privately held leading innovator in the field of multi-column chromatography (MCC) instrumentation and technology for the downstream purification of biologics.
· In September 2021, Repligen and Navigo completed their co-development of a novel affinity ligand that addresses aggregation issues associated with pH-sensitive antibodies and Fc-fusion proteins. This ligand, NGL-Impact HipH, is produced and supplied to Purolite for use in a platform usage resin product.
· In May 2021, The Life Sciences business of GE Healthcare was acquired by Danaher Corporation and rebranded as Cytiva.
Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=19196962
About MarketsandMarkets™
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.
The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.
The global protein A resin market is projected to reach USD 2.1 billion by 2028 from USD 1.2 billion in 2022, growing at a CAGR of 9.8% during the forecast period. Rising technological advancements primarily drive the growth of this market in protein A resin, rise in demand for miniaturize protein engineered product used in disease diagnoses and therapeutics. equipment further supports the market growth. However, higher initial investment impedes the market growth.
Protein A Resin Market: Competitive Landscape and Key Developments
The protein A resin business is very competitive, with both established companies and newcomers competing for the same market share. As of 2022, the key players operating in the global protein A resin market are Danaher Corporation (US), Merck KGAa (Germany), Repligen Corporation (US), Tosoh Bioscience LLC (Japan), Thermo Fisher Scientific (US), Agilent Technologies Inc. (US), and PerkinElmer (US) among others.
Get PDF Brochure With Latest Insights @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=19196962
Danaher Corporation (US)
Danaher Corporation is a US-based company that designs, manufactures, and markets medical, industrial, and commercial products and services. The company operates through three business segments, namely, Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences business segment offers protein A resin products. This segment is further classified into Filtration, Mass Spectrometry, Cellular Analysis, Lab Automation & Centrifugation, Microscopy, and Genomics Consumables. In FY 2021, the US accounted for 38.3% of the company’s revenue, followed by China (13.5%), Germany (5%), and all other countries (43.2%). The company's presence across diverse geographies shields it from risks associated with adverse economic trends in a single region. It also provides it with exposure to a large addressable market, thus enhancing its topline.
Merck KGAA (Germany)
Merck KGaA is another major player in the protein A resin market. The company is a leading provider of chromatography consumables across the globe. It primarily focuses on expansions and new product launches as its key growth strategies to expand its presence in the global market. Merck has a significant focus on innovation. Over the last few years, the company has increased its R&D activities with a focus on providing its customers with advanced products. Through strong R&D, the company is extending its patent portfolio, which can help Merck gain an advantage over its competitors. Merck is consistently introducing new chromatography products in the market. The company is also focused on enhancing its geographic presence through expansions.
Objectives of the Study
· To define, describe, and forecast the protein A resin market on the basis of product, type, application, end user, and region
· To provide detailed information regarding the major factors influencing the growth potential of the global market (drivers, restraints, opportunities, challenges, and trends)
· To analyze the micro markets with respect to individual growth trends, future prospects, and contributions to the global market
· To analyze key growth opportunities in the global market for key stakeholders and provide details of the competitive landscape for market leaders
· To forecast the size of market segments and/or subsegments with respect to five major regions, namely, North America (US and Canada), Europe (Germany, France, the UK, Italy, Spain, and the RoE), Asia Pacific (Japan, China, India, Australia, South Korea, and the RoAPAC), and rest of the world.
· To profile the key players in the global market and comprehensively analyze their market shares and core competencies
· To track and analyze the competitive developments undertaken in the global protein A resin market, such as product launches, agreements, expansions, and & acquisitions
Buy This Complete Business Report @ https://www.marketsandmarkets.com/Purchase/purchase_reportNew.asp?id=19196962
Global Protein A Resin Market – Regional Scope
The global Protein A resin market is segmented into five major regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Among these, the North America region is expected to hold the largest share in the global Protein A resin market. This can be attributed to the presence of well-established biopharmaceutical companies in the region and the availability of advanced infrastructure for biopharmaceutical manufacturing. Moreover, the rapid growth of the biopharmaceutical industry in the region is also expected to propel the growth of the Protein A resin market in North America.
Europe is the second-largest region in the global Protein A resin market, due to the presence of a large number of biopharmaceutical companies and contract research organizations in the region. The Asia Pacific is expected to be the fastest-growing region in the global Protein A resin market, owing to the increasing demand for biopharmaceuticals in the region. The growing research and development activities in the region are also expected to contribute to the growth of the Protein A resin market in the region.
Recent Developments
· In September 2022, As part of its charitable efforts through the Agilent Foundation, Agilent Technologies partnered with Delaware State University (DSU) to boost the number of minority students who choose STEM careers.
· In October 2021, Tosoh Biosciences LLC completed the acquisition of Semba Biosciences, a privately held leading innovator in the field of multi-column chromatography (MCC) instrumentation and technology for the downstream purification of biologics.
· In September 2021, Repligen and Navigo completed their co-development of a novel affinity ligand that addresses aggregation issues associated with pH-sensitive antibodies and Fc-fusion proteins. This ligand, NGL-Impact HipH, is produced and supplied to Purolite for use in a platform usage resin product.
· In May 2021, The Life Sciences business of GE Healthcare was acquired by Danaher Corporation and rebranded as Cytiva.
Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=19196962
About MarketsandMarkets™
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.
The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.
The global protein A resin market is projected to reach USD 2.1 billion by 2028 from USD 1.2 billion in 2022, growing at a CAGR of 9.8% during the forecast period. Rising technological advancements primarily drive the growth of this market in protein A resin, rise in demand for miniaturize protein engineered product used in disease diagnoses and therapeutics. equipment further supports the market growth. However, higher initial investment impedes the market growth.
Protein A Resin Market: Competitive Landscape and Key Developments
The protein A resin business is very competitive, with both established companies and newcomers competing for the same market share. As of 2022, the key players operating in the global protein A resin market are Danaher Corporation (US), Merck KGAa (Germany), Repligen Corporation (US), Tosoh Bioscience LLC (Japan), Thermo Fisher Scientific (US), Agilent Technologies Inc. (US), and PerkinElmer (US) among others.
Get PDF Brochure With Latest Insights @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=19196962
Danaher Corporation (US)
Danaher Corporation is a US-based company that designs, manufactures, and markets medical, industrial, and commercial products and services. The company operates through three business segments, namely, Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences business segment offers protein A resin products. This segment is further classified into Filtration, Mass Spectrometry, Cellular Analysis, Lab Automation & Centrifugation, Microscopy, and Genomics Consumables. In FY 2021, the US accounted for 38.3% of the company’s revenue, followed by China (13.5%), Germany (5%), and all other countries (43.2%). The company's presence across diverse geographies shields it from risks associated with adverse economic trends in a single region. It also provides it with exposure to a large addressable market, thus enhancing its topline.
Merck KGAA (Germany)
Merck KGaA is another major player in the protein A resin market. The company is a leading provider of chromatography consumables across the globe. It primarily focuses on expansions and new product launches as its key growth strategies to expand its presence in the global market. Merck has a significant focus on innovation. Over the last few years, the company has increased its R&D activities with a focus on providing its customers with advanced products. Through strong R&D, the company is extending its patent portfolio, which can help Merck gain an advantage over its competitors. Merck is consistently introducing new chromatography products in the market. The company is also focused on enhancing its geographic presence through expansions.
Objectives of the Study
· To define, describe, and forecast the protein A resin market on the basis of product, type, application, end user, and region
· To provide detailed information regarding the major factors influencing the growth potential of the global market (drivers, restraints, opportunities, challenges, and trends)
· To analyze the micro markets with respect to individual growth trends, future prospects, and contributions to the global market
· To analyze key growth opportunities in the global market for key stakeholders and provide details of the competitive landscape for market leaders
· To forecast the size of market segments and/or subsegments with respect to five major regions, namely, North America (US and Canada), Europe (Germany, France, the UK, Italy, Spain, and the RoE), Asia Pacific (Japan, China, India, Australia, South Korea, and the RoAPAC), and rest of the world.
· To profile the key players in the global market and comprehensively analyze their market shares and core competencies
· To track and analyze the competitive developments undertaken in the global protein A resin market, such as product launches, agreements, expansions, and & acquisitions
Buy This Complete Business Report @ https://www.marketsandmarkets.com/Purchase/purchase_reportNew.asp?id=19196962
Global Protein A Resin Market – Regional Scope
The global Protein A resin market is segmented into five major regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Among these, the North America region is expected to hold the largest share in the global Protein A resin market. This can be attributed to the presence of well-established biopharmaceutical companies in the region and the availability of advanced infrastructure for biopharmaceutical manufacturing. Moreover, the rapid growth of the biopharmaceutical industry in the region is also expected to propel the growth of the Protein A resin market in North America.
Europe is the second-largest region in the global Protein A resin market, due to the presence of a large number of biopharmaceutical companies and contract research organizations in the region. The Asia Pacific is expected to be the fastest-growing region in the global Protein A resin market, owing to the increasing demand for biopharmaceuticals in the region. The growing research and development activities in the region are also expected to contribute to the growth of the Protein A resin market in the region.
Recent Developments
· In September 2022, As part of its charitable efforts through the Agilent Foundation, Agilent Technologies partnered with Delaware State University (DSU) to boost the number of minority students who choose STEM careers.
· In October 2021, Tosoh Biosciences LLC completed the acquisition of Semba Biosciences, a privately held leading innovator in the field of multi-column chromatography (MCC) instrumentation and technology for the downstream purification of biologics.
· In September 2021, Repligen and Navigo completed their co-development of a novel affinity ligand that addresses aggregation issues associated with pH-sensitive antibodies and Fc-fusion proteins. This ligand, NGL-Impact HipH, is produced and supplied to Purolite for use in a platform usage resin product.
· In May 2021, The Life Sciences business of GE Healthcare was acquired by Danaher Corporation and rebranded as Cytiva.
Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=19196962
About MarketsandMarkets™
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.
The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.
Single-Use
Bioreactors Market in terms of revenue was estimated to be worth $4.2
billion in 2023 and is poised to reach $10.0 billion by 2028, growing at a CAGR
of 19.0% from 2023 to 2028 according to a new report by MarketsandMarkets™.
Request for FREE Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=49113750
Factors such as the increasing adoption of single-use
bioreactors among startups and SMEs, lower operational complexity of single-use
bioreactors compared to conventional stainless-steel bioreactors, reduced
energy and water consumption, growing size of the biologics and biosimilars
market, and technological advancements in single-use bioreactors.
Browse in-depth TOC on "Single-Use Bioreactors
Market"
408 - Tables
48 - Figures
345 – Pages
TOP Single-Use Bioreactors MARKET PLAYER
The single-use bioprocessing market is highly consolidated
with majority of the market share taken up by key players such as Thermo Fisher
Scientific (US), Danaher Corporation (US), Sartorius Stedim Biotech S.A.
(France), and Merck KGaA (Germany). The key players in this market are
increasingly focusing on strategic expansions, partnerships, and product
approvals to expand their manufacturing capabilities and increase market
presence.
Sartorius Stedim Biotech held the
leading position in the single-use bioprocessing market. Sartorius focuses on
strengthening its position in the market by adopting organic and inorganic
strategies such as product launches and expansions. During the past three
years, Sartorius Stedim Biotech launched SUB systems such as BIOSTAT STR
Generation 3 Single-Use Bioreactor, BIOSTAT RM TX Single-Use Bioreactor, and
BIOSTAT STR. Sartorius acquired Danaher’s Life Science portfolio, which is
complementary to the portfolio of Sartorius’s laboratory and bioprocess
business. the company also expanded their operations in Puerto Rico.
Thermo Fisher Scientific is the
second-largest player in the single-use bioprocessing market. Thermo Fisher
Scientific operates in the single-use bioprocessing market through the life
science solutions business segment. To further increase its share in the
single-use bioprocessing market, the company focuses on growth strategies such
as acquisitions and expansion. the company expanded its business in the US. The
company also made investments worth ~USD 650 million to enhance their
single-use bioprocessing capabilities and increase their market share.
The Asia Pacific region is the fastest-growing region of
the single-use bioreactors market.
Based on the region, the single-use bioreactors market is
segmented into five major regions: North America, Europe, Asia Pacific, Latin
America, and the Middle East & Africa. The Asia Pacific market is expected
to register the highest CAGR during the forecast period. Factors such as the
growing biopharmaceutical industry, rising investments by pharmaceutical &
biotechnology companies, and the growing number of CROs & CMOs in several
Asia Pacific countries are supporting the growth of the market in the region.
Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=49113750
About
MarketsandMarkets™
MarketsandMarkets™
has been recognized as one of America's best management consulting
firms by Forbes, as per their recent report.
MarketsandMarkets™
is a blue ocean alternative in growth consulting and program management,
leveraging a man-machine offering to drive supernormal growth for progressive
organizations in the B2B space. We have the widest lens on emerging
technologies, making us proficient in co-creating supernormal growth for
clients.
Earlier
this year, we made a formal transformation into one of America's best
management consulting firms as per a survey conducted by Forbes.
The
B2B economy is witnessing the emergence of $25
trillion of new revenue streams that are substituting existing
revenue streams in this decade alone. We work with clients on growth programs,
helping them monetize this $25 trillion opportunity
through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to
Execution, Market Share Gain, Account Enablement, and Thought Leadership
Marketing.
Built
on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B
companies - helping them stay relevant in a disruptive ecosystem. Our insights
and strategies are molded by our industry experts, cutting-edge AI-powered
Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our
Market Intelligence Cloud) integrates our research, facilitates an analysis of
interconnections through a set of applications, helping clients look at the
entire ecosystem and understand the revenue shifts happening in their industry.
To
find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.
According to the lastest report published by MarketsandMarkets, "Synthetic Biology Market by Tools (Oligonucleotides, Enzymes, Synthetic Cells), Technology (Genome Engineering, Bioinformatics), Applications (Tissue Regeneration, Biofuel, Food, Agriculture, Consumer Care, Environmental)- Global Forecast to 2027, the global synthetic biology market size is projected to reach USD 35.7 billion by 2027 from 11.4 billion in 2022, at a CAGR of 25.6% during the forecast period.
Request for Sample PDF @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=889
Factors such as diversified applications of synthetic biology, rising R&D funding and growing initiatives in synthetic biology, declining cost of DNA sequencing and synthesizing, and increasing investments in the market are propelling the growth of this market.
The oligonucleotides and synthetic DNA segment accounted for the largest share of the tool segment in the synthetic biology market
Based on tool, the synthetic biology market is broadly segmented into oligonucleotides & synthetic DNA, enzymes, cloning technology kits, synthetic cells, chassis organisms, and xeno-nucleic acids., oligonucleotides & synthetic DNA accounted for the largest share of the synthetic biology market for tools. This segment's large share can be attributed to factors such as rising demand for synthetic DNA, synthetic RNA, and synthetic genes, which are used in a wide range of applications.
The medical applications segment accounted for the largest share of the application segment in the synthetic biology market
Based on application, the synthetic biology market is categorized into three segments—medical applications, industrial applications, food & agriculture, and environmental applications. In 2021, medical applications segment accounted for the largest share of synthetic biology market. Factors such as the adoption of synthetic biology techniques and tools in regenerative medicine, use of synthetic biology tools in drug discovery and development are projecting the segmental growth.
Enquiry Before Buying: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=889
Asia Pacific is likely to grow at higher double digit during the forecast period.
The Asia Pacific region is estimated to grow at the highest CAGR in the synthetic biology market during the forecast period, this is mainly due to factors such the increasing investment in research & development, emergence of new market players in synthetic biology market.
Key Market Players
Some of the prominent players in the synthetic biology market are Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Agilent Technologies (US), Novozymes (Denmark), Ginkgo Bioworks (US), Amyris (US), Precigen, Inc. (US), GenScript (China), Twist Bioscience (US), Synthetic Genomics (US), Codexis (US), Synthego (US), Creative Enzymes (US), and among others.
Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=889
Don’t miss out on business opportunities in Synthetic Biology Market. Speak to our analyst and gain crucial industry insighs that will help your businessgrow.
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
The global primary cells market is projected to reach USD
2.8 billion by 2028 from USD 1.7 billion in 2023, at a CAGR of 10.5% during the
forecast period. The growth of this market can be attributed to factors such as
the is the growing advantages of primary human cells over cell lines, growth in
pharmaceutical & biotechnology industries, increasing demand for monoclonal
antibodies, government investments for cell-based research, and increasing
cancer research.
Request To
Download Sample of This Strategic Report @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=32854960
Primary cells refer to cells taken directly from living
tissues of animals or humans and are then processed to establish them for use
in appropriate cell therapies. Primary cells are widely used in various
applications, including 3D cell culture, virology, cancer research, stem cell
therapy, and tissue replacement.
This study involved four major activities in estimating the
current size of the primary cells market. Exhaustive secondary research was
carried out to collect information on the market, its peer markets, and its
parent market. The next step was to validate these findings, assumptions, and
sizing with industry experts across the value chain through primary research.
North America is the largest regional market for primary
cells market
The primary cells market is segmented into four major
regions, namely, North America, Europe, Asia Pacific, and the Rest of the World
(RoW). North America accounted for the largest share in the primary cells
market. The growth in the North American primary cells market can be attributed
to increasing funding for cancer research, growing life science research
sector, expansion of the healthcare sector, and the high adoption of stem cell
therapy & cell immunotherapies for the treatment of cancer and chronic diseases.
Key
Market Players
Thermo Fisher
Scientific, Inc. (US), Merck KGaA (Germany), Lonza (Switzerland), Cell
Biologics, Inc. (US), PromoCell GmbH (Germany), HemaCare Corporation (US),
ZenBio, Inc. (US), STEMCELL Technologies, Inc. (Canada), Corning Incorporated
(US), AllCells (US), American Type Culture Collection (US), Axol Bioscience
Ltd. (UK), iXCells Biotechnologies (US), Neuromics (US), StemExpress (US),
BioIVT (US), ScienCell Research Laboratories, Inc. (US), PPA Research Group,
Inc. (US), Creative Bioarray (US), BPS Bioscience, Inc. (US), Epithelix Sàrl
(Switzerland), ReachBio LLC (US), AcceGen (US), Sekisui XenoTech, LLC (US), and
Biopredic International (France).
For a detailed look at our Table of Contents
@ https://www.marketsandmarkets.com/Market-Reports/primary-cells-market-32854960.html
This report categorizes the primary cells market into
the following segments and subsegments:
By Origin
By Type
By End User
By Region
Recent Developments
Buy-Now this Premium Report @ https://www.marketsandmarkets.com/Purchase/purchase_reportNew.asp?id=32854960
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on
30,000 high growth niche opportunities/threats which will impact 70% to 80% of
worldwide companies’ revenues. Currently servicing 7500 customers worldwide
including 80% of global Fortune 1000 companies as clients. Almost 75,000 top
officers across eight industries worldwide approach MarketsandMarkets™ for
their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are
tracking global high growth markets following the "Growth Engagement Model
– GEM". The GEM aims at proactive collaboration with the clients to
identify new opportunities, identify most important customers, write
"Attack, avoid and defend" strategies, identify sources of
incremental revenues for both the company and its competitors.
MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top
players across leaders, emerging companies, innovators, strategic players)
annually in high growth emerging segments. MarketsandMarkets™ is determined to
benefit more than 10,000 companies this year for their revenue planning and
help them take their innovations/disruptions early to the market by providing
them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and
market research platform, "Knowledgestore" connects over 200,000
markets and entire value chains for deeper understanding of the unmet insights
along with market sizing and forecasts of niche markets.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
The global biologics safety testing market is projected to reach USD 6.8 billion by 2027 from USD 3.6 billion in 2022, at a CAGR of 13.3% during the forecast period. The growth of the global biologics safety testing market is driven by factors such as the growing developments of biologics and biosimilars, increased concerns over the cell culture contamination, and rising investments in biopharmaceutical research and development.
Get Access to Sample Pages + Covid-19 impact analysis: https://www.marketsandmarkets.com/requestsampleNew.asp?id=34624144
Key Market Players
Prominent players in the biologics safety testing market are Charles River Laboratories, Inc. (US), Lonza (Switzerland), Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Labcorp (US), F. Hoffmann-La Roche Ltd. (Switzerland), Agilent Technologies, Inc. (US), Sartorius AG (Germany), and Lonza (Switzerland).
CHARLES RIVER LABRATORIES (US)
Charles River is one of the key players in the biologics safety testing market. It is a service and early-stage contract research organization (CRO). The company develops a diverse portfolio of discovery & safety assessment services by providing a suite of products and services to support its clients’ manufacturing activities. The company operates through three reporting segments, namely, Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Support (Manufacturing).
LONZA (SWITZERLAND)
Lonza is a key player in the biologics safety testing market. The company has a large number of manufacturing and R&D facilities worldwide. The company's wide geographic presence and high production capacity deliver quality products worldwide.
THERMO FISCHER SCIENTIFIC (US)
Thermo Fisher Scientific offers analytical instruments, equipment, reagents, and consumables for research, discovery, analysis, diagnostics, and manufacturing. The company operates through four principal product segments—Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.
For In-Depth Competitive Analysis, Read a Report: @ https://www.marketsandmarkets.com/Market-Reports/biologics-safety-testing-market-34624144.html
The Asia Pacific region is the fastest growing region of the Biologics safety testing market
The Asia Pacific market is projected to witness the highest growth rate during the forecast period. Rapid growth in outsourcing preclinical, clinical, and laboratory testing services to APAC countries is expected to drive market growth during the forecast period. Several companies are focusing on increasing their market shares and customer base in the region to capitalize on these opportunities in the Asia Pacific market.
Recent Developments
· Merck KGaA (Germany) invested in expanding its biosafety testing capacity at Rockville, Maryland, US. This site will provide biosafety testing and analytical development services in the US.
· Eurofins Scientific (Luxembourg) acquired Wessling Hungary, a food, environmental, and BioPharma product testing laboratory in Hungary. This acquisition helped expand Eurofins' biopharma testing business in Europe.
· Lonza (Switzerland) launched the PyroCell Monocyte Activation Test to detect non-endotoxin pyrogens and reduce interferences from complex drug products, such as biologics-based pharmaceuticals.
Buy-Now this Premium Report @ https://www.marketsandmarkets.com/Purchase/purchase_reportNew.asp?id=34624144
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441